Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Shiue Chou

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Journal of Personalized Medicine|January 21, 2022
Preferred Treatment with Curative Intent for Left Lateral Segment Early Hepatocellular Carcinoma under the Era of Minimal Invasive SurgeryTsung-Han Wu, Yu-Chao Wang, Hao-Chien Hung, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Human Cytomegalovirus Is Associated with Lower HCC Recurrence in Liver Transplant PatientsPo-Jung Hsu, Hao-Chien Hung, Jin-Chiao Lee, et al.
Immunity, Inflammation and Disease|November 4, 2020
Plasma cytomegalovirus DNA load predicts outcomes in liver transplant recipientsHao-Chien Hung, Po-Jung Hsu, Jin-Chiao Lee, et al.
World Journal of Hepatology|October 3, 2022
Modified preoperative score to predict disease-free survival for hepatocellular carcinoma patients with surgical resectionsYin Lai, Jin-Chiao Lee, Hao-Chien Hung, et al.
The Kaohsiung Journal of Medical Sciences|November 13, 2025
A Simplified Risk Assessment Tool to Predict Post Deceased Donor Liver Transplantation Outcomes: A Single, Highly Experienced Medical Center in TaiwanJie-Lan Jhang, Hao-Chien Hung, Yin Lai, et al.
Digestive Diseases and Sciences|June 1, 2024
Liver Resection Criteria for Patients with Hepatocellular Carcinoma and Multiple Tumors Based on Total Tumor VolumeHao-Wen Shih, Yin Lai, Hao-Chien Hung, et al.
Clinical Transplantation|July 6, 2017
Prognostic impact and risk factors of low body mass index in patients undergoing liver transplantationJin-Chiao Lee, Wael M A Doush, Yu-Chao Wang, et al.
Transplantation Direct|September 22, 2025
Pretransplant Immune Checkpoint Inhibitor Treatment for Intermediate-advanced Hepatocellular Carcinoma in Living Donor Liver TransplantationChih-Hsien Cheng, Hao-Wen Shi, Yin Lai, et al.
Annals of Transplantation|January 5, 2022
Reconstruction of Separated Intrahepatic Ducts Using the Cystic and Common Hepatic Ducts in Right-Lobe Living-Donor Liver Transplantation: Experiences of Surgical Techniques, Biliary Complications, and Outcomes in a Single InstitutionPo-Jung Hsu, Hao-Chien Hung, Ching-Sung Lee, et al.
Viruses|March 30, 2023
Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant RecipientsWei-Chen Lee, Hao-Chien Hung, Jin-Chiao Lee, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Journal of Personalized Medicine|January 21, 2022
Preferred Treatment with Curative Intent for Left Lateral Segment Early Hepatocellular Carcinoma under the Era of Minimal Invasive SurgeryTsung-Han Wu, Yu-Chao Wang, Hao-Chien Hung, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Human Cytomegalovirus Is Associated with Lower HCC Recurrence in Liver Transplant PatientsPo-Jung Hsu, Hao-Chien Hung, Jin-Chiao Lee, et al.
Immunity, Inflammation and Disease|November 4, 2020
Plasma cytomegalovirus DNA load predicts outcomes in liver transplant recipientsHao-Chien Hung, Po-Jung Hsu, Jin-Chiao Lee, et al.
World Journal of Hepatology|October 3, 2022
Modified preoperative score to predict disease-free survival for hepatocellular carcinoma patients with surgical resectionsYin Lai, Jin-Chiao Lee, Hao-Chien Hung, et al.
The Kaohsiung Journal of Medical Sciences|November 13, 2025
A Simplified Risk Assessment Tool to Predict Post Deceased Donor Liver Transplantation Outcomes: A Single, Highly Experienced Medical Center in TaiwanJie-Lan Jhang, Hao-Chien Hung, Yin Lai, et al.
Digestive Diseases and Sciences|June 1, 2024
Liver Resection Criteria for Patients with Hepatocellular Carcinoma and Multiple Tumors Based on Total Tumor VolumeHao-Wen Shih, Yin Lai, Hao-Chien Hung, et al.
Clinical Transplantation|July 6, 2017
Prognostic impact and risk factors of low body mass index in patients undergoing liver transplantationJin-Chiao Lee, Wael M A Doush, Yu-Chao Wang, et al.
Transplantation Direct|September 22, 2025
Pretransplant Immune Checkpoint Inhibitor Treatment for Intermediate-advanced Hepatocellular Carcinoma in Living Donor Liver TransplantationChih-Hsien Cheng, Hao-Wen Shi, Yin Lai, et al.
Annals of Transplantation|January 5, 2022
Reconstruction of Separated Intrahepatic Ducts Using the Cystic and Common Hepatic Ducts in Right-Lobe Living-Donor Liver Transplantation: Experiences of Surgical Techniques, Biliary Complications, and Outcomes in a Single InstitutionPo-Jung Hsu, Hao-Chien Hung, Ching-Sung Lee, et al.
Viruses|March 30, 2023
Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant RecipientsWei-Chen Lee, Hao-Chien Hung, Jin-Chiao Lee, et al.
Pageof 10